144 related articles for article (PubMed ID: 35466335)
1. QM/MM and MM MD simulations on decontamination of the V-type nerve agent VX by phosphotriesterase: toward a comprehensive understanding of steroselectivity and activity.
Fan F; Zheng Y; Fu Y; Zhang Y; Zheng H; Lyu C; Chen L; Huang J; Cao Z
Phys Chem Chem Phys; 2022 May; 24(18):10933-10943. PubMed ID: 35466335
[TBL] [Abstract][Full Text] [Related]
2. Variants of Phosphotriesterase for the Enhanced Detoxification of the Chemical Warfare Agent VR.
Bigley AN; Mabanglo MF; Harvey SP; Raushel FM
Biochemistry; 2015 Sep; 54(35):5502-12. PubMed ID: 26274608
[TBL] [Abstract][Full Text] [Related]
3. QM/MM and MM MD Simulations on Enzymatic Degradation of the Nerve Agent VR by Phosphotriesterase.
Yu J; Fu Y; Cao Z
J Phys Chem B; 2023 Aug; 127(34):7462-7471. PubMed ID: 37584503
[TBL] [Abstract][Full Text] [Related]
4. Overcoming the Challenges of Enzyme Evolution To Adapt Phosphotriesterase for V-Agent Decontamination.
Bigley AN; Desormeaux E; Xiang DF; Bae SY; Harvey SP; Raushel FM
Biochemistry; 2019 Apr; 58(15):2039-2053. PubMed ID: 30893549
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic neutralization of the chemical warfare agent VX: evolution of phosphotriesterase for phosphorothiolate hydrolysis.
Bigley AN; Xu C; Henderson TJ; Harvey SP; Raushel FM
J Am Chem Soc; 2013 Jul; 135(28):10426-32. PubMed ID: 23789980
[TBL] [Abstract][Full Text] [Related]
6. The evolution of phosphotriesterase for decontamination and detoxification of organophosphorus chemical warfare agents.
Bigley AN; Raushel FM
Chem Biol Interact; 2019 Aug; 308():80-88. PubMed ID: 31100274
[TBL] [Abstract][Full Text] [Related]
7. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
[TBL] [Abstract][Full Text] [Related]
8. Enzymes for the homeland defense: optimizing phosphotriesterase for the hydrolysis of organophosphate nerve agents.
Tsai PC; Fox N; Bigley AN; Harvey SP; Barondeau DP; Raushel FM
Biochemistry; 2012 Aug; 51(32):6463-75. PubMed ID: 22809162
[TBL] [Abstract][Full Text] [Related]
9. Phosphotriesterase variants with high methylphosphonatase activity and strong negative trade-off against phosphotriesters.
Briseño-Roa L; Timperley CM; Griffiths AD; Fersht AR
Protein Eng Des Sel; 2011 Jan; 24(1-2):151-9. PubMed ID: 21037279
[TBL] [Abstract][Full Text] [Related]
10. Post-VX exposure treatment of rats with engineered phosphotriesterases.
Stigler L; Köhler A; Koller M; Job L; Escher B; Potschka H; Thiermann H; Skerra A; Worek F; Wille T
Arch Toxicol; 2022 Feb; 96(2):571-583. PubMed ID: 34962578
[TBL] [Abstract][Full Text] [Related]
11. Molecular binding scaffolds increase local substrate concentration enhancing the enzymatic hydrolysis of VX nerve agent.
Lang X; Hong X; Baker CA; Otto TC; Wheeldon I
Biotechnol Bioeng; 2020 Jul; 117(7):1970-1978. PubMed ID: 32239488
[TBL] [Abstract][Full Text] [Related]
12. Structural determinants for the stereoselective hydrolysis of chiral substrates by phosphotriesterase.
Tsai PC; Fan Y; Kim J; Yang L; Almo SC; Gao YQ; Raushel FM
Biochemistry; 2010 Sep; 49(37):7988-97. PubMed ID: 20695627
[TBL] [Abstract][Full Text] [Related]
13. Water-Regulated Mechanisms for Degradation of Pesticides Paraoxon and Parathion by Phosphotriesterase: Insight from QM/MM and MD Simulations.
Fu Y; Fan F; Wang B; Cao Z
Chem Asian J; 2022 Jul; 17(14):e202200439. PubMed ID: 35586954
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a phosphodiesterase capable of hydrolyzing EA 2192, the most toxic degradation product of the nerve agent VX.
Ghanem E; Li Y; Xu C; Raushel FM
Biochemistry; 2007 Aug; 46(31):9032-40. PubMed ID: 17630782
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective hydrolysis of organophosphate nerve agents by the bacterial phosphotriesterase.
Tsai PC; Bigley A; Li Y; Ghanem E; Cadieux CL; Kasten SA; Reeves TE; Cerasoli DM; Raushel FM
Biochemistry; 2010 Sep; 49(37):7978-87. PubMed ID: 20701311
[TBL] [Abstract][Full Text] [Related]
16. Detoxification of organophosphate nerve agents by bacterial phosphotriesterase.
Ghanem E; Raushel FM
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):459-70. PubMed ID: 15982683
[TBL] [Abstract][Full Text] [Related]
17. Degradation of pesticides diazinon and diazoxon by phosphotriesterase: insight into divergent mechanisms from QM/MM and MD simulations.
Fu Y; Zhang Y; Fan F; Wang B; Cao Z
Phys Chem Chem Phys; 2022 Jan; 24(2):687-696. PubMed ID: 34927643
[TBL] [Abstract][Full Text] [Related]
18. Molecular Docking, Metal Substitution and Hydrolysis Reaction of Chiral Substrates of Phosphotriesterase.
de Castro AA; Caetano MS; Silva TC; Mancini DT; Rocha EP; da Cunha EF; Ramalho TC
Comb Chem High Throughput Screen; 2016; 19(4):334-44. PubMed ID: 27012528
[TBL] [Abstract][Full Text] [Related]
19. Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro.
Goldsmith M; Eckstein S; Ashani Y; Greisen P; Leader H; Sussman JL; Aggarwal N; Ovchinnikov S; Tawfik DS; Baker D; Thiermann H; Worek F
Arch Toxicol; 2016 Nov; 90(11):2711-2724. PubMed ID: 26612364
[TBL] [Abstract][Full Text] [Related]
20. Catalytic activity and stereoselectivity of engineered phosphotriesterases towards structurally different nerve agents in vitro.
Köhler A; Escher B; Job L; Koller M; Thiermann H; Skerra A; Worek F
Arch Toxicol; 2021 Aug; 95(8):2815-2823. PubMed ID: 34160649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]